Q/C TECHNOLOGIES, INC. (QCLS)
In Vitro & In Vivo Diagnostic Substances
Latest Price
$0.44
TTM P/E
--
Normalized P/E
--
Div Yield
--
Book Value
1.95
P/B Ratio
0.23
Institutional Ownership
9.0% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Quinn Opportunity Partners LLC | 123.0K | -- | 1.50% | -88.4K | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT LLC | 115.0K | -- | 1.40% | +77.5K | 2026-06-30 |
| JANE STREET GROUP, LLC | 87.2K | -- | 1.07% | -38.9K | 2026-06-30 |
| GEODE CAPITAL MANAGEMENT, LLC | 70.7K | -- | 0.86% | +23.3K | 2026-06-30 |
| UBS Group AG | 58.9K | -- | 0.72% | -19.1K | 2026-06-30 |
| Balyasny Asset Management L.P. | 57.7K | -- | 0.70% | -- | 2026-06-30 |
| HRT FINANCIAL LP | 50.4K | -- | 0.62% | +28.0K | 2026-06-30 |
| ADAR1 Capital Management, LLC | 50.0K | -- | 0.61% | -- | 2026-06-30 |
| VANGUARD FIDUCIARY TRUST CO | 43.1K | -- | 0.53% | +27.5K | 2026-06-30 |
| STATE STREET CORP | 25.3K | -- | 0.31% | +12.4K | 2026-06-30 |